Clinical trials
Recruiting Triple Negative Breast Neoplasms trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 2 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 8 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 26 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institut Curie | 3 |
| European Institute of Oncology | 2 |
| Ohio State University Comprehensive Cancer Center | 2 |
| Centre Henri Becquerel | 1 |
| City of Hope Medical Center | 1 |
| First Affiliated Hospital of Zhejiang University | 1 |
| Indiana University | 1 |
| Institut Cancerologie de l'Ouest | 1 |
| Jessica Mezzanotte Sharpe | 1 |
| King Faisal Specialist Hospital & Research Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 26 |
| Breast Neoplasms | 11 |
| Ovarian Neoplasms | 3 |
| Uterine Cervical Neoplasms | 2 |
| Vulvar Neoplasms | 2 |
| Breast Carcinoma In Situ | 1 |
| Breast Neoplasms, Male | 1 |
| Carcinoma, Intraductal, Noninfiltrating | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Carcinoma, Renal Cell | 1 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.